Estimate the coverage of Breast Cancer Patients Referred to Cancer Research Center in Jahrom city from 2016 to 2019


1 Student Research Committee, Jahrom University Of medical Science, Jahrom, Iran

2 Assistant professor in Epidemiology, Research center for non -Communicable Disease, Jahrom University of Medical Sciences, Jahrom, Iran

3 Assistant Professor, Department of Surgery, Women’s Health and Disease Research Center, Faculty of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran


Introduction: Jahrom Cancer Research Center is a neo-center that has been get started since 2016 and so far no study
has been done to determine the coverage of patients referred to this center. The aim of this study was to estimate the coverage of patients referred to the Cancer Research Center and in addition to determine the sensitivity of the cancer registration system during the study years.
Materials & Methods: In this study, the information of breast cancer patients has been extracted from three data sources (death, cancer registration system and cancer research center). The corrected number of cases of breast cancer was estimated using log linear method, during the study years. The coverage of patients referred to the Cancer Research Center and the sensitivity of the registration system were calculated based on the estimated number of cases.
Results: In the study, 205 patients with breast cancer referred to the Cancer Research Center between 2016 and 2019, and the coverage of breast cancer patients by this center were 62%. The sensitivity of the breast cancer registration system was estimated to be 53.9% in Jahrom University of Medical Sciences.
Conclusion: The present study showed that a relatively acceptable coverage of breast cancer patients referred to this
center. But the sensitivity of the breast cancer registration system is low despite the population base cancer registry system. Increasing interaction and cooperation between the cancer registry system and the Cancer Research Center could have a significant impact on increasing the sensitivity of cancer registry system.


1Roshandel GRR, Partoypoor E, Ghanbari M otlagh A.Iranian national cancer registry guideline. 95.01thed.Tehran: Deputy of Health,Center for Non-Communicable Disease Control, Cancer OfficeIranianNational Population-based Cancer Registry
Secretariate; 2016.2. World Health Organization.cancer. 2021 [cited-06-2021]. Available from:
topics/cancer#tab=tab_1.3. Naghavi M . M ortality profile in 18 provinces of Iran(2001). Tehran: Iranian M inistry of Health andM edical Education, Deputy of Health; 2003.4. Khodadost M , Yavari P, Babaei M , Sarvi F, HashemiNazari S. Evaluation completeness of esophaguscancer registry in ardabil using log-linear model. IranJ Epidemiol. 2015;11(3):11-22.5. M ousavi S, Alamolhoda A, Gouya M , Lickiss N.Implementation of comprehensive national cancercontrol program in Iran: An experience in adeveloping country Ann Oncol. 2008;19(2):398-400.6. Lankarani KB, Khosravizadegan Z, Rezaianzadeh A,Honarvar B, M oghadami M , Faramarzi H, et al. Datacoverage of a cancer registry in southern Iran beforeand after implementation of a population-basedreporting system: a 10-year trend study. BM C HealthServ Res. 2013;13(1):1-7.7. M odirian M , Rahimzadeh S, Cheraghi Z, Khosravi A,Salimzadeh H, Kompani F, et al. Quality evaluation ofnational cancer registry system in Iran: study protocol.Arch Iran M ed. 2014;17(3):193-7.8. Parkin D. Comparability and quality control in cancerregistration. IARC Tech Rep. 1994;19:18-9.9. Chiang CJ, You SL, Chen CJ, Yang YW, Lo WC, LaiM S. Quality assessment and improvement ofnationwide cancer registration system in Taiwan: areview. Jpn J Clin Oncol. 2015;45(3):291-6.10.M ohammadi G, Akbari M E, M ehrabi Y, GhanbariM otlagh A. Quality assessment of the national cancerregistry in Iran: completeness and validity. Iran JCancer Prev. 2016;9(6).11.Zahedi R, M olavi Vardanjani H, Baneshi M R,Haghdoost AA, M alekpour Afshar R, Zolala F.Another Evidence of an Increasing Trend in theIncidence of Breast Cancer in Developing Countriesover the Recent Years. M iddle East J Cancer. 2021;12(4):506-14.12.Shimakawa Y, Bah E, Wild CP, Hall AJ. Evaluationof data quality at the Gambia national cancer registry.Int J Cancer. 2013;132(3):658-65.13.Sharifian R, SedaghatNia M H, Nematolahi M , ZareN, Barzegari S. Estimation of completeness of cancerregistration for patients referred to Shiraz selectedcenters through a two source capture re-capturemethod, 2009 data. Asian Pac J Cancer Prev.2015;16(13):5549-56.14.Dortag E, Bahrampour A, Haghdost A, Zendedel K,Jaberipour M , M arzeban M . Completeness of farsprovince deaths registry on cancer death using capturerecaptures method. J North Khorasan Univ M ed Sci.2011; 3 (5) :33-43.15.M olavi Vardanjani H. Assessing completeness ofcase ascertainment in Kerman cancer registry during2007-2011 [dissertation]. Kerman,Iran: Sch. Health,Kerman Univ M ed Sci; 2015.16.M arzban M , Haghdoost A-A, Dortaj E, BahrampourA, Zendehdel K. Completeness and underestimationof cancer mortality rate in Iran: a report from Farsprovince in Southern Iran. Arch Iran M ed.2015;18(3):160-6.17.Kroll M E, M urphy M F, Carpenter LM , Stiller CA.Childhood cancer registration in Britain: capture-recapture estimates of completeness of ascertainment.Br J Cancer. 2011;104(7):1227-33.